封面
市场调查报告书
商品编码
1512678

全球乳酸菌益生菌市场 - 2024-2031

Global Lactobacillus Probiotic Market - 2024-2031

出版日期: | 出版商: DataM Intelligence | 英文 213 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年,全球乳酸菌益生菌市场规模达27亿美元,预计到2031年将达到49亿美元,2024-2031年预测期间复合年增长率为8.9%。

市场对促进肠道健康的功能性食品和饮料的需求显着增加。乳酸菌益生菌越来越融入优格、冰沙和膳食补充剂等产品中,满足消费者对方便、促进健康的选择的需求。持续的科学研究透过发现乳酸菌益生菌的新健康益处来推动市场,并推动消费者兴趣和市场成长。

例如,2024 年3 月21 日,TrueNorth 推出了「Sensibiotics」品牌的尖端益生菌解决方案,以解决与敏感肠道和女性健康相关的问题,战略重点是印度不断扩大的肠道健康市场,预计将达到49.1 亿美元,以及女性健康市场,预计收入为 9 亿美元。这种创新配方将鼠李糖乳桿菌 GG (ATCC 53103)(被认为是全球研究最广泛的益生菌菌株之一)与布拉酵母菌结合。

亚太市场的功能性食品和饮料产业正在经历显着成长。乳酸菌益生菌正被纳入各种产品以及新颖的应用中,以满足注重健康的消费者的需求。益生菌配方和输送系统的创新正在增强区域市场。微胶囊化和其他技术的进步正在提高乳酸菌益生菌的稳定性和功效,使其对消费者更具吸引力。

动力学

人们越来越认识到益生菌的健康益处

人们对益生菌健康益处的认识不断提高,正在推动全球乳酸菌益生菌市场的发展。随着消费者越来越了解益生菌对消化健康、免疫功能和整体健康的正面影响,对乳酸菌益生菌的需求正在上升。大量科学研究、媒体报导和健康运动都强调了维持健康肠道微生物组的重要性,从而提高了人们的认识。

製造商正在开发各种乳酸菌益生菌产品,包括膳食补充剂、功能性食品和饮料,以满足不断增长的消费者需求。市场正在加大研发投入,以提高乳酸菌益生菌的功效和稳定性,进一步增强消费者信心和市场采用率。

例如,2023年9月7日,韩国hy(原名韩国养乐多)推出了膏霜类化妆品Leti 7714三重提拉抗衰老霜。该产品是该公司推出的第二款含有皮肤乳酸菌7714 的化妆品产品,皮肤乳酸菌7714 是一种培养乳酸菌的发酵衍生物,该产品已进军化妆品市场,其产品由利用其专有乳酸菌的发酵成分製成。

扩大营养保健品产业

不断扩大的营养保健品产业正在推动全球乳酸菌益生菌市场的发展。随着消费者对增强健康产品的需求不断增长,营养保健品产业不断发展,乳酸菌益生菌市场正经历显着成长。营养保健品,包括膳食补充剂、功能性食品和饮料最终用户,通常含有益生菌以增强其健康益处,从而增加了乳酸菌菌株的市场需求。

市场上营养保健品公司与研究机构之间的合作日益增加。这些合作关係旨在验证乳酸菌益生菌的健康声明,提高产品可信度和消费者信任度。因此,市场的特征是有科学根据的乳酸菌益生菌产品不断涌入,吸引了注重健康的消费者。

例如,2023年9月9日,SIG和AnaBio Technologies合作推出了世界上首款长保质期益生菌酸奶,标誌着益生菌饮料和无菌包装的重大进步。这项开创性的成就预示着一种新型产品类别的出现:采用无菌纸盒包装和带嘴袋包装的益生菌饮料,无需冷藏即可延长保质期。

发展中地区消费者意识缺乏

发展中地区消费者意识的缺乏正在限制全球乳酸菌益生菌市场。在这些地区,对益生菌健康益处的了解有限以及对其使用的误解阻碍了市场的成长。儘管乳酸菌益生菌具有潜在的健康优势,但市场在接触和教育发展中地区的消费者方面面临挑战。

发展中地区的消费者不太可能寻找或信任这些产品,通常会优先考虑更传统或熟悉的健康解决方案。因此,乳酸菌益生菌的市场渗透率仍然有限,影响了整体市场成长。市场参与者在行销和分销方面遇到困难。如果没有消息灵通的消费者基础,推广乳酸菌益生菌产品的努力就会面临重大障碍。

目录

第 1 章:方法与范围

第 2 章:定义与概述

第 3 章:执行摘要

第 4 章:动力学

  • 影响因素
    • 司机
      • 人们越来越认识到益生菌的健康益处
      • 扩大营养保健品产业
    • 限制
      • 发展中地区消费者意识缺乏
    • 机会
    • 影响分析

第 5 章:产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 俄乌战争影响分析
  • DMI 意见

第 6 章:COVID-19 分析

第 7 章:按形式

  • 液体
  • 粉末
  • 胶囊
  • 药片
  • 其他的

第 8 章:按配销通路

  • 零售药房
  • 医院药房
  • 超级市场和大卖场
  • 网路药房
  • 其他的

第 9 章:按申请

  • 食品和饮料最终用户
  • 药品
  • 膳食补充剂
  • 其他的

第 10 章:最终用户

  • 婴儿
  • 孩子们
  • 成年人
  • 老年人

第 11 章:按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 俄罗斯
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第 12 章:竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 13 章:公司简介

  • Mitushi BioPharma
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Goerlich Pharma GmbH
  • Nutra Healthcare Private Limited
  • Fermentis Life Sciences
  • Unique Biotech
  • Culturelle Probiotic Canada
  • BJP Laboratories
  • ProbioFerm
  • Fido Pharma Pvt. Ltd.
  • Probiotics Australia

第 14 章:附录

简介目录
Product Code: FB8527

Overview

Global Lactobacillus Probiotic Market reached US$ 2.7 billion in 2023 and is expected to reach US$ 4.9 billion by 2031, growing with a CAGR of 8.9% during the forecast period 2024-2031.

The market is witnessing a significant increase in demand for functional foods and beverages that promote gut health. Lactobacillus probiotics are increasingly incorporated into products like yogurts, smoothies, and dietary supplements, meeting consumer demand for convenient, health-boosting options. Ongoing scientific research drives the market by uncovering new health benefits of lactobacillus probiotics and propels consumer interest and market growth.

For instance, on March 21, 2024, TrueNorth introduced cutting-edge probiotic solutions under the brand name 'Sensibiotics' to address issues related to sensitive gut and feminine health, with a strategic focus on India's expanding gut health market, projected to reach $4.91 billion, and the feminine health market, projected at $0.9 billion in revenues. This innovative formulation combines lactobacillus rhamnosus GG (ATCC 53103), recognized as one of the most extensively researched probiotic strains globally, with Saccharomyces Boulardii.

The Asia-Pacific market is experiencing significant growth in the functional foods and beverages sector. Lactobacillus probiotics are being incorporated into various products, as well as novel applications, catering to health-conscious consumers. Innovations in probiotic formulations and delivery systems are enhancing the regional market. Advances in microencapsulation and other technologies are improving the stability and efficacy of lactobacillus probiotics, making them more appealing to consumers.

Dynamics

Growing Awareness about the Health Benefits of Probiotics

Growing awareness about the health benefits of probiotics is driving the global lactobacillus probiotic market. As consumers become increasingly informed about the positive impacts of probiotics on digestive health, immune function, and overall well-being, the demand for lactobacillus probiotics is rising. This heightened awareness is fueled by a plethora of scientific studies, media coverage, and health campaigns that emphasize the importance of maintaining a healthy gut microbiome.

Manufacturers are developing a wide range of lactobacillus probiotic products, including dietary supplements, functional foods, and beverages, to cater to the growing consumer demand. The market is witnessing increased investment in research and development to enhance the efficacy and stability of lactobacillus probiotics, further boosting consumer confidence and market adoption.

For instance, on September 7, 2023, South Korea's hy, previously known as Korea Yakult, introduced the Leti 7714 Triple Lift-up Anti-aging Cream, a cream-type cosmetic. This product is the company's second cosmetic offering that incorporates skin lactobacillus 7714, a fermented derivative of cultured lactic acid bacteria has ventured into the cosmetics market with products made from fermented ingredients utilizing its proprietary lactic acid bacteria.

Expanding Nutraceutical Industry

The expanding nutraceutical industry is driving the global lactobacillus probiotic market. As the nutraceutical sector grows, driven by increasing consumer demand for health-enhancing products, the market for lactobacillus probiotics is experiencing significant growth. Nutraceuticals, which encompass dietary supplements, functional foods, and beverEnd-Users, often incorporate probiotics to enhance their health benefits, thereby boosting the market demand for lactobacillus strains.

The market is seeing increased collaborations between nutraceutical companies and scientific research institutions. These partnerships aim to validate the health claims of lactobacillus probiotics, enhancing product credibility and consumer trust. As a result, the market is characterized by a steady influx of scientifically-backed lactobacillus probiotic products that appeal to health-conscious consumers.

For instance, on September 9, 2023, SIG and AnaBio Technologies collaborated to introduce the world's first long-life probiotic yogurt, marking a significant advancement in probiotic beverages and aseptic packaging. This pioneering achievement heralds the emergence of a novel product category: probiotic beverages packaged in aseptic carton packs and spouted pouches, offering extended shelf stability without the need for refrigeration.

Lack of Consumer Awareness in Developing Regions

Lack of consumer awareness in developing regions is restraining the global lactobacillus probiotic market. In these regions, limited knowledge about the health benefits of probiotics and misconceptions about their use are hindering market growth. Despite the potential health advantages of lactobacillus probiotics, the market is facing challenges in reaching and educating consumers in developing areas.

Consumers in developing regions are less likely to seek out or trust these products, often prioritizing more traditional or familiar health solutions. Consequently, market penetration for lactobacillus probiotics remains limited, impacting overall market growth. Market players are encountering difficulties in marketing and distribution. Without a well-informed consumer base, efforts to promote lactobacillus probiotic products face significant obstacles.

Segment Analysis

The global lactobacillus probiotic market is segmented based on form, distribution channel, application, end-user and region.

Increasing Consumer Focus on Health and Wellness

The dietary supplements segment holds the largest share of the global lactobacillus probiotic market. In an era where individuals are increasingly prioritizing their health and wellness, dietary supplements, particularly those containing lactobacillus probiotics, have become a popular choice. These supplements are widely recognized for their benefits in supporting digestive health, enhancing immune function, and maintaining overall wellness, propelling the dietary supplements segment to the forefront of the lactobacillus probiotic market.

Market innovations are also playing a critical role in the dominance of the dietary supplements segment. Companies within the probiotic industry are continuously investing in research and development to create advanced and more effective probiotic formulations. These innovations include the development of multi-strain probiotic supplements, time-release capsules, and targeted delivery systems that enhance the efficacy and stability of lactobacillus probiotics.

Geographical Penetration

Growing Health-conscious Consumer Base and Innovations in Asia-Pacific

Asia-Pacific is positioned to dominate the global lactobacillus probiotic market. The Asia-Pacific region has a long history of consuming fermented foods, which naturally contain probiotics. This cultural familiarity with probiotics makes it easier for consumers to embrace lactobacillus probiotic supplements and functional foods, propelling the lactobacillus probiotic market growth.

Consumers are proactively seeking products that support long-term health and wellness, leading to a surge in demand for lactobacillus probiotics as part of a preventive health regimen. The market in Asia-Pacific is characterized by significant investments in research and development. Companies are innovating with new formulations and delivery methods, such as probiotic beverages, snacks, and supplements, tailored to local tastes and preferences, enhancing market appeal.

COVID-19 Impact Analysis

The market experienced supply chain disruptions due to lockdowns and restrictions. These disruptions affected the production and distribution of lactobacillus probiotic products, leading to temporary short-end users and delays in product availability. However, with the focus on preventive health rising during the pandemic, the market has seen a surge in demand for functional foods and beverages. Products containing lactobacillus probiotics have become popular as consumers look for ways to enhance their health through diet.

The pandemic accelerated the shift to online retail as consumers avoided physical stores. The market saw a significant increase in the sale of lactobacillus probiotic products through e-commerce platforms, which provided a convenient and safe way for consumers to purchase health supplements. Companies have developed new formulations and delivery formats for lactobacillus probiotics, to cater to the growing health-conscious consumer base.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine war has significantly impacted the global lactobacillus probiotic market through a series of complex and interrelated factors. The most prominent effect has been on supply chain disruptions. Both Russia and Ukraine are crucial players in the global agricultural market, providing essential raw materials used in the production of lactobacillus probiotics. The conflict has led to severe interruptions in the supply of these raw materials, which has in turn affected the manufacturing processes of probiotic producers.

Market demand has also experienced fluctuations due to the economic instability triggered by the war. Consumer spending patterns have shifted, with many individuals prioritizing essential goods over discretionary items like health supplements. This change in consumer behavior has led to a potential decline in demand for lactobacillus probiotics in regions heavily affected by the conflict.

By Form

  • Liquid
  • Powder
  • Capsule
  • Tablet
  • Others

By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarkets and Hypermarkets
  • Online Pharmacy
  • Others

By Application

  • Food and Beverage
  • Drugs
  • Dietary Supplements
  • Others

By End-User

  • Infants
  • Children
  • Adults
  • Seniors

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • On April 27, 2023, Gnosis by Lesaffre expanded its probiotic lineup with the introduction of LifeinU L. rhamnosus GG 350, a new quality specification of their well-established probiotic strain LifeinU L. rhamnosus GG. Lactobacillus rhamnosus GG is widely utilized in various products around the world to promote digestive health.
  • On February 11, 2022, Indian scientists launched a breakthrough in probiotic research, introducing a next-generation probiotic with promising implications for longevity and healthy aging. The probiotic bacterium, Lactobacillus Plantarum JBC5, represents a significant discovery in the quest for beneficial bacteria to enhance well-being, particularly in fermented dairy products.
  • On February 26, 2021, Sweet Cures, a globally recognized manufacturer and retailer of natural health food supplements, introduced an innovative line of probiotics, featuring up to 17 live strains of bacteria supported by clinical research. Expanding on the popularity of Sweet Cures Probiotic Blend Capsules, the company has partnered with industry leader Danisco to develop the new UniBac range.

Competitive Landscape

The major global players in the lactobacillus probiotic market include Mitushi BioPharma, Goerlich Pharma GmbH, Nutra Healthcare Private Limited, Fermentis Life Sciences, Unique Biotech, Culturelle Probiotic Canada, BJP Laboratories, ProbioFerm, Fido Pharma Pvt. Ltd., and Probiotics Australia.

Why Purchase the Report?

  • To visualize the global lactobacillus probiotic market segmentation based on form, distribution channel, application, end-user and region, as well as understand critical commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous global lactobacillus probiotic market-level data points with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of critical products of all the major players.

The global lactobacillus probiotic market report would provide approximately 70 tables, 68 figures, and 213 users.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Form
  • 3.2. Snippet by Distribution Channel
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Awareness about the Health Benefits of Probiotics
      • 4.1.1.2. Expanding Nutraceutical Industry
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Consumer Awareness in Developing Regions
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Form

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 7.1.2. Market Attractiveness Index, By Form
  • 7.2. Liquid*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Powder
  • 7.4. Capsule
  • 7.5. Tablet
  • 7.6. Others

8. By Distribution Channel

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 8.1.2. Market Attractiveness Index, By Distribution Channel
  • 8.2. Retail Pharmacy*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Hospital Pharmacy
  • 8.4. Supermarkets and Hypermarkets
  • 8.5. Online Pharmacy
  • 8.6. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Food and Bever End-User*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Drugs
  • 9.4. Dietary Supplements
  • 9.5. Others

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Infants*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Children
  • 10.4. Adults
  • 10.5. Seniors

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Russia
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Mitushi BioPharma*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Goerlich Pharma GmbH
  • 13.3. Nutra Healthcare Private Limited
  • 13.4. Fermentis Life Sciences
  • 13.5. Unique Biotech
  • 13.6. Culturelle Probiotic Canada
  • 13.7. BJP Laboratories
  • 13.8. ProbioFerm
  • 13.9. Fido Pharma Pvt. Ltd.
  • 13.10. Probiotics Australia

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us